BIORESORBABLE SCAFFOLD FOR THE TREATMENT OF LESIONS IN SMALL CORONARY ARTERIES: IVUS INSIGHTS FROM THE ABSORB JAPAN TRIAL

被引：1
|
作者：
Okada, Kozo [1 ]
Kitahara, Hideki [1 ]
Otagiri, Kyuhachi [1 ]
Tanaka, Shigemitsu [1 ]
Kimura, Takumi [1 ]
Yock, Paul [1 ]
Fitzgerald, Peter [1 ]
Kimura, Takeshi [1 ]
Honda, Yasuhiro [1 ]
机构：
[1] Stanford Univ, Stanford Cardiovasc Inst, Div Cardiovasc Med, Stanford, CA 94305 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)30369-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1253-121
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [41] Comparison between treatment of "established" versus complex "off-label" coronary lesions with Absorb bioresorbable scaffold implantation: results from the GABI-R registry
    Huseynov, A.
    Baumann, S.
    Nef, H.
    Riemer, T.
    Schneider, S.
    Pfannebecker, T.
    Achenbach, S.
    Mehilli, J.
    Gori, T.
    Woehrle, J.
    Zahn, R.
    Schmermund, A.
    Richard, G.
    Hamm, C.
    Akin, I.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1755 - 1755
  • [42] Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry
    Cayla, Guillaume
    Koning, Rene
    Fajadet, Jean
    Sainsous, Joel
    Carrie, Didier
    Elhadad, Simon
    Tarragano, Francois
    Lefevre, Thierry
    Ranc, Sylvain
    Ghostine, Said
    Garot, Philippe
    Marco, Frederic
    Maillard, Luc
    Motreff, Pascal
    Le Breton, Herve
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2019, 112 (02) : 113 - 123
  • [43] Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    Grimfjard, Per
    James, Stefan
    Persson, Jonas
    Angeras, Oskar
    Koul, Sasha
    Omerovic, Elmir
    Varenhorst, Christoph
    Lagerqvist, Bo
    Erlinge, David
    EUROINTERVENTION, 2017, 13 (11) : 1304 - 1311
  • [44] Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold
    Vanhaverbeke, Maarten
    McCutcheon, Keir
    Dubois, Christophe
    Bennett, Johan
    ACTA CARDIOLOGICA, 2018, 73 (04) : 413 - 414
  • [45] Will this trial change my practice? ABSORB II trial (a bioresorbable vascular scaffold versus drug-eluting stent in coronary disease)
    De Palma, Rodney
    Byrne, Robert A.
    van Geuns, Robert-Jan
    Pilgrim, Thomas
    Jueni, Peter
    Al-Rashdan, Ibrahim
    EUROINTERVENTION, 2015, 11 (03) : 366 - 368
  • [46] Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial
    Kereiakes, Dean J.
    Ellis, Stephen G.
    Popma, Jeffrey J.
    Fitzgerald, Peter J.
    Samady, Habib
    Jones-McMeans, Jennifer
    Zhang, Zhen
    Cheong, Wai-Fung
    Su, Xiaolu
    Ben-Yehuda, Ori
    Stone, Gregg W.
    AMERICAN HEART JOURNAL, 2015, 170 (04) : 641 - +
  • [47] Clinical Outcomes of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Final 5-Year Results From the ABSORB III Trial
    Ellis, Stephen
    Kereiakes, Dean
    Stone, Gregg
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B166 - B166
  • [48] Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry
    Landolff, Quentin
    Lefevre, Thierry
    Fajadet, Jean
    Sainsous, Joel
    Lhermusier, Thibault
    Elhadad, Simon
    Tarragano, Francois
    Ranc, Sylvain
    Ghostine, Said
    Cayla, Guillaume
    Marco, Frederic
    Garot, Philippe
    Maillard, Luc
    Motreff, Pascal
    Delarche, Nicolas
    De Labriolle, Axel
    Pansieri, Michel
    Morelle, Jean-Francois
    Cazaux, Pierre
    Moulichon, Marc Eric
    Chopat, Patrick
    Angoulvant, Denis
    Bataille, Vincent
    Le Breton, Herve
    Koning, Rene
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2022, 115 (10) : 505 - 513
  • [49] ABSORB Cohort B Trial: 9 Months Clinical Results of the Evaluation of the Bioresorbable Everolimus-Eluting Vascular Scaffold (BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions
    Ormiston, Lohn
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B9 - B9
  • [50] Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights from the Serial IVUS analysis of the pivotal, prospective, multicentre, DESolve NX Trial
    Costa, Jose D., Jr.
    Schofer, Joachim
    Verheye, Stefan
    Toyloy, Sara
    Chamie, Daniel
    Bbhat, Vinayak
    Costa, Ricardo A.
    Witzenbichler, Bernhard
    Morrison, Lynn
    Yan, John
    Sousa, Amanda
    Sousa, J. Eduardo
    Abizaid, Alexandre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B181 - B181
12345